Vamsi Labs Limited
Solapur, Maharashtra
Est. 1991
About Company
Description
VAMSI LABS LTD.an ISO 9001:2015, ISO 14001:2015 and ISO 45001:2018 company, is one of the major manufacturers of Active Pharmaceutical Ingredients (API's) in India. The factory is located in the industrial area of Solapur, Maharashtra, India. Anti-asthmatic (respiratory), Anti-Migraine and Anti-Psychotic API's are the main products. Today 60% of the sales are from antiasthma products.
Contact Information
Primary Phone
Secondary Phone
Registered Address
Full Address
Address: Factory & regd. office : A-14, A-15, A-31, A-32 & A-33, MIDC Area, Chincholi, Solapur - 413255
City
Solapur
State
Maharashtra
Pincode
413255
Country
India
Business Information
Business Types
Manufacturer
API Supplier
Year Established
1991
Manufacturing Units
1
Legal & Compliance
CIN Number
U99999MH1991PTC059750
Certifications & Approvals
WHO-GMP
Not Certified
ISO
Certified
GMP
Not Certified
FSSAI
Not Certified
USFDA
Not Approved
EU-GMP
Not Certified
UK-MHRA
Not Approved
WHO Prequalified
No
PCD/Franchise Information
PCD Franchisor
No
Products
Total products: 12
| Product Name | Dosage Form | Composition | Therapeutic Category |
|---|---|---|---|
| (9-isopropyl-9-azabicyclo[3,3,1]non-3-yl)methanol | - | IPRATROPIUM BROMIDE | - |
| (9-isopropyl-9-azabicyclo[3,3,1]non-3-yl)methanol | - | IPRATROPIUM BROMIDE | - |
| 4-Oxo-2-Phenylbutanoic acid | - | IPRATROPIUM BROMIDE | - |
| 4-Oxo-2-Phenylbutanoic acid | - | IPRATROPIUM BROMIDE | - |
| Methyl 2, 2-dithienyl glycolate (Methyl Glycolate) | - | TIOTROPIUM BROMIDE | - |
| Methyl 2, 2-dithienyl glycolate (Methyl Glycolate) | - | TIOTROPIUM BROMIDE | - |
| MORE TABS EVENTS STATUTORY SECTION REPORT DIRECTOR REPORT EC-Approved Letter Six Monthly compliance report Six Monthly Report 6 monthly compliance report Oct 2022 to March 2023 33rd Annual Report 2022 | Tablet | - | - |
| MORE TABS EVENTS STATUTORY SECTION REPORT DIRECTOR REPORT EC-Approved Letter Six Monthly compliance report Six Monthly Report 6 monthly compliance report Oct 2022 to March 2023 33rd Annual Report 2022 | Tablet | - | - |
| N-Isopropyl Noratropine (IPT-II) | - | IPRATROPIUM BROMIDE | - |
| N-Isopropyl Noratropine (IPT-II) | - | IPRATROPIUM BROMIDE | - |
| Scopine-DI, 2-dithienyl glycolate (Scopine ester) | - | TIOTROPIUM BROMIDE | - |
| Scopine-DI, 2-dithienyl glycolate (Scopine ester) | - | TIOTROPIUM BROMIDE | - |
Social Media
Company Status
Status
Active
Verification
Verified
Statistics
Profile Views
77
Total Inquiries
0